Fischer; Yvan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fischer; Yvan.The latest application filed is for "pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics".

Company Profile

0.8.15

Fischer; Yvan - Barsinghausen DE
Fischer, Yvan - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives Grant 8,273,905 - Moloney , et al. September 25, 2	2012-09-25
Pharmaceutical Compositions Comprising NEP-Inhibitors, Inhibitors of the Endogenous Endothelin Producing System and Diuretics App 20100323012 - STRAUB; Matthias ; et al.	2010-12-23
Pharmaceutical Compositions Comprising NEP-Inhibitors, Inhibitors of the Endogenous Endothelin Producing System and AT1 Receptor Antagonists App 20100203132 - Ziegler; Dieter ; et al.	2010-08-12
Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives Grant 7,714,150 - Moloney , et al. May 11, 2	2010-05-11
Aminoalkyl-Amidomethyl-Substituted 2-(4-Sulphonylamino)- 3-Hydroxy-3,4-Dihydro-2H-Chroman-6-yl Derivatives App 20090203686 - Moloney; Brian ; et al.	2009-08-13
Use of amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl-compounds in the treatment of cardiac arrhythmia and other disease states Grant 7,534,903 - Sykes , et al. May 19, 2	2009-05-19
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them Grant 7,452,875 - Hoeltje , et al. November 18, 2	2008-11-18
Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them Grant 7,427,611 - Hoeltje , et al. September 23, 2	2008-09-23
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them Grant 7,410,962 - Hoeltje , et al. August 12, 2	2008-08-12
Use of Amidomethyl-Substituted 2-(4-Sulfonylamino)-3-Hydroxy-3,4-Dihydro-2H-Chromen-6-yl-Compounds in the Treatment of Cardiac Arrhythmia and Other Disease States App 20080113999 - SYKES; David ; et al.	2008-05-15
Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them Grant 7,368,582 - Sykes , et al. May 6, 2	2008-05-06
Amidomethyl-Substituted 1-(Carboxyalkyl) Cyclopentyl-Carbonylamino-Benzazepine-N-Acetic Acid Compounds, Process and Intermediate Products for Their Preparation and Pharmaceutical Compositions Containing Them App 20080085889 - Hoeltje; Dagmar ; et al.	2008-04-10
Pharmaceutical Combination Comprising An Adenosine A1 Antagonist And A Radiocontrast Media App 20080045551 - Hocher; Berthold ; et al.	2008-02-21
Use Of Adenosine A1 Antagonists In Radiocontrast Media Induced Nephropathy App 20080027082 - Hocher; Berthold ; et al.	2008-01-31
Amidomethyl-substituted 1-(carboxyalkyl) Cyclopentyl-carbonylamino-benzazepine-n-acetic Acid Compounds, Process And Intermediate Products For Their Preparation And Pharmaceutical Compositions Containing Them App 20070265244 - Hoeltje; Dagmar ; et al.	2007-11-15
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them Grant 7,262,184 - Hoeltje , et al. August 28, 2	2007-08-28
Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them App 20060281732 - Hoeltje; Dagmar ; et al.	2006-12-14
Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives App 20060252821 - Moloney; Brian ; et al.	2006-11-09
Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics App 20060205625 - Straub; Matthias ; et al.	2006-09-14
Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists App 20050288272 - Ziegler, Dieter ; et al.	2005-12-29
Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chrom- en-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them App 20050148659 - Sykes, David ; et al.	2005-07-07
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzaze- pine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them App 20050119247 - Hoeltje, Dagmar ; et al.	2005-06-02
Compounds with NEP/MP-inhibitory activity and uses thereof App 20040162345 - Berger, Claudia ; et al.	2004-08-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.